Preparation of osthole-loaded nano-vesicles for skin delivery: Characterization, in vitro skin permeation and preliminary in vivo pharmacokinetic studies.

[1]  S. Davaran,et al.  Nanoethosomes for Dermal Delivery of Lidocaine. , 2015, Advanced pharmaceutical bulletin.

[2]  Y. Chiu,et al.  Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation , 2015, Journal of Biomedical Science.

[3]  A. Ascenso,et al.  Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes , 2015, International journal of nanomedicine.

[4]  Ho Yee Cheung,et al.  Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine , 2015, Evidence-based complementary and alternative medicine : eCAM.

[5]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[6]  Liuqing Di,et al.  Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. , 2014, International journal of pharmaceutics.

[7]  A. Attama,et al.  Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus , 2014, Expert opinion on drug delivery.

[8]  Mandip Singh,et al.  Design, Synthesis of Novel Lipids as Chemical Permeation Enhancers and Development of Nanoparticle System for Transdermal Drug Delivery , 2013, PloS one.

[9]  K. Hua,et al.  Osthole Mitigates Progressive IgA Nephropathy by Inhibiting Reactive Oxygen Species Generation and NF-κB/NLRP3 Pathway , 2013, PloS one.

[10]  Yong-yan Bei,et al.  Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole , 2013, International journal of nanomedicine.

[11]  A. Ahad,et al.  Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. , 2013, International journal of pharmaceutics.

[12]  S. Jose,et al.  Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation , 2011, Journal of advanced pharmaceutical technology & research.

[13]  Yi Zhang,et al.  Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway , 2011, Journal of experimental & clinical cancer research : CR.

[14]  Zhigang Qi,et al.  Osthole Ameliorates Insulin Resistance by Increment of Adiponectin Release in High-Fat and High-Sucrose-Induced Fatty Liver Rats , 2010, Planta medica.

[15]  H. Zhen,et al.  Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats , 2010, Brain Research.

[16]  N. Chen,et al.  Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus. , 2010, European journal of pharmacology.

[17]  Julie Schappler,et al.  Drug–protein binding: a critical review of analytical tools , 2010, Analytical and bioanalytical chemistry.

[18]  Di Chen,et al.  Osthole Stimulates Osteoblast Differentiation and Bone Formation by Activation of β-Catenin–BMP Signaling , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  V. Koul,et al.  Flexible polymerosomes--an alternative vehicle for topical delivery. , 2009, Colloids and surfaces. B, Biointerfaces.

[20]  J. Luszczki,et al.  Osthole suppresses seizures in the mouse maximal electroshock seizure model. , 2009, European journal of pharmacology.

[21]  Z. Gu,et al.  Inhibitory effect of osthole on alcohol-induced fatty liver in mice. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  Cheng-Wei Lu,et al.  Osthole and imperatorin, the active constituents of Cnidium monnieri (L.) Cusson, facilitate glutamate release from rat hippocampal nerve terminals , 2008, Neurochemistry International.

[23]  Nigel J Waters,et al.  Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. , 2008, Journal of pharmaceutical sciences.

[24]  Hanqi Zhang,et al.  Fluorimetric and mass spectrometric study of the interaction of beta-cyclodextrin and osthole. , 2007, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[25]  O. Abdallah,et al.  Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.

[26]  Z. Gu,et al.  Therapeutic effect of osthole on hyperlipidemic fatty liver in rats , 2007, Acta Pharmacologica Sinica.

[27]  Ya-Ling Hsu,et al.  Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[28]  Massimo Fresta,et al.  Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[29]  S. Antimisiaris,et al.  Arsenic Trioxide Liposomes: Encapsulation Efficiency and In Vitro Stability , 2004, Journal of liposome research.

[30]  Chen Dawei,et al.  Effect of enhancers on percutaneous absorption of osthol across the excised full thickness rat skin. , 2003, Die Pharmazie.

[31]  S. Jain,et al.  Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation , 2003, Drug development and industrial pharmacy.

[32]  T. Matsumiya,et al.  Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. , 2002, Biological & pharmaceutical bulletin.

[33]  H. Nojima,et al.  Inhibition of itch-scratch response by fruits of Cnidium monnieri in mice. , 2001, Biological & pharmaceutical bulletin.

[34]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[35]  D. Paolino,et al.  In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. , 2000, International journal of pharmaceutics.

[36]  G. Cevc,et al.  Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.

[37]  G. Cevc.  Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.